TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7861627

Group type: EXPERIMENTAL
Intervention: 2W continuous+TIW
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: 4W continuous+TIW
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: 8W continuous+TIW
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Interferon treatment
Number of subjects: 115
Study: 2024591

Group type: EXPERIMENTAL
Intervention: Nonionic iopamidol (Isovue‐370)
Number of subjects: 913

Group type: COMPARATOR
Intervention: Ionic contrast media, meglumine sodium diatrizoate (Renografin‐76)
Number of subjects: 913
Study: 7043754

Group type: EXPERIMENTAL
Intervention: Mianserin 30 mg (increased to 60 mg from week 2)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Clomipramine 75 mg (increased to 150 mg from week 2)
Number of subjects: 42
Study: 29976075

Group type: EXPERIMENTAL
Intervention: Advance care planning intervention (details on dosage and duration not available)
Number of subjects: 200
Study: 29730827

Group type: EXPERIMENTAL
Intervention: INSPIRE + PST
Number of subjects: 755

Group type: EXPERIMENTAL
Intervention: INSPIRE alone
Number of subjects: 755

Group type: COMPARATOR
Intervention: Control (delayed INSPIRE access)
Number of subjects: 755
Study: 26796956

Group type: EXPERIMENTAL
Intervention: Nintendo™ Wii console intervention, balance board exercises, 2 sessions per week for 3 months
Number of subjects: 760

Group type: COMPARATOR
Intervention: Usual habits (control group)
Number of subjects: 760
Study: 25113556

Group type: EXPERIMENTAL
Intervention: Intraperitoneal ropivacaine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 120
Study: 22287671

Group type: EXPERIMENTAL
Intervention: No supplemental vitamin A for 227 d
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: No supplemental vitamin A for 112 d followed by 115 d of supplemental vitamin A
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Supplemental vitamin A for 112 d followed by no supplemental vitamin A for 115 d
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Supplemental vitamin A for 227 d
Number of subjects: 164

Group type: COMPARATOR
Intervention: Cattle without supplemental vitamin A
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Cattle with supplemental vitamin A
Number of subjects: 164
Study: 18803678

Group type: EXPERIMENTAL
Intervention: Recombinant human TSH (rhTSH)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Hypothyroidism
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Both groups (rhTSH and hypothyroidism)
Number of subjects: 74
Study: 16636856

Group type: EXPERIMENTAL
Intervention: Training (T)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 58
Study: 15218522

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005%/Timolol maleate 0.5%
Number of subjects: 33

Group type: COMPARATOR
Intervention: Dorzolamide 2%/Timolol maleate 0.5%
Number of subjects: 33
Study: 11834238

Group type: EXPERIMENTAL
Intervention: 6% cellulose sulfate gel (2.5 mL and 5.0 mL doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 6% cellulose sulfate gel (2.5 mL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conceptrol (nonoxynol-9)
Number of subjects: 0

Group type: COMPARATOR
Intervention: K-Y jelly
Number of subjects: 0

Group type: COMPARATOR
Intervention: All products (6% cellulose sulfate gel, Conceptrol, K-Y jelly)
Number of subjects: 0
Study: 9727542

Group type: EXPERIMENTAL
Intervention: abciximab
Number of subjects: 483

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 483
Study: 7506854

Group type: EXPERIMENTAL
Intervention: Finasteride for twelve months
Number of subjects: 895

Group type: COMPARATOR
Intervention: PSA values alone with a cutoff of 10 ng/mL at baseline and 5 ng/mL after twelve months of treatment
Number of subjects: 895
Study: 2735734

Group type: EXPERIMENTAL
Intervention: Nifedipine 30 mg/day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Reference group (no treatment)
Number of subjects: 20
Study: 1167048

Group type: EXPERIMENTAL
Intervention: Topical methenamine gel stick
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 31726894

Group type: EXPERIMENTAL
Intervention: Intratumoral injection of DNX-2401 without tumor resection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intratumoral injection of DNX-2401 followed by surgical resection 14 days later with a second injection into the resection cavity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DNX-2401 treatment
Number of subjects: 0
Study: 28862375

Group type: EXPERIMENTAL
Intervention: Endovascular revascularization
Number of subjects: 358
Study: 26308291

Group type: EXPERIMENTAL
Intervention: Pro‐En (21 g of leucine‐enriched whey protein with carbohydrate (9 g) and fat (3 g))
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Pro (21 g of leucine‐enriched whey protein without carbohydrate and fat)
Number of subjects: 45

Group type: COMPARATOR
Intervention: En (isocaloric mixture containing carbohydrate and fat only)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Pro‐En vs Pro
Number of subjects: 45

Group type: COMPARATOR
Intervention: Pro‐En vs En
Number of subjects: 45
Study: 22153730

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 226

Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 226

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 226

Group type: COMPARATOR
Intervention: Control group (Olanzapine)
Number of subjects: 226
Study: 21459430

Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stent
Number of subjects: 1140

Group type: COMPARATOR
Intervention: Everolimus-eluting stent
Number of subjects: 1140
Study: 18697183

Group type: EXPERIMENTAL
Intervention: Herba Epimedii water extract
Number of subjects: 90

Group type: COMPARATOR
Intervention: Water placebo
Number of subjects: 90
Study: 16595786

Group type: EXPERIMENTAL
Intervention: Home care nurse-directed treatment strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Primary care physician-directed treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 12411756

Group type: EXPERIMENTAL
Intervention: Normal saline for 24 h (1 ml/kg/h) beginning 12 h prior to catheterization
Number of subjects: 53

Group type: COMPARATOR
Intervention: Unrestricted oral fluids
Number of subjects: 53
Study: 11236819

Group type: EXPERIMENTAL
Intervention: Cognitive intervention (training in face‐name associations, spaced retrieval, and cognitive stimulation)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Mock (placebo) intervention
Number of subjects: 37
Study: 9709277

Group type: EXPERIMENTAL
Intervention: Mammography screening
Number of subjects: 48569

Group type: COMPARATOR
Intervention: Control group (no screening)
Number of subjects: 48569
Study: 8474062

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) 10 mg im on Day 0, no corticosteroid (Group 1)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Methotrexate (MTX) 10 mg im on Day 0, prednisolone 15 mg/day per os from D-3 (Group 2)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) 10 mg im on Day 0, long-term prednisolone treatment 15 mg/day (Group 3)
Number of subjects: 33
Study: 3761104

Group type: EXPERIMENTAL
Intervention: Metoclopramide (0.3 mg/kg/dose)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Metoclopramide (0.1 mg/kg/dose)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Metoclopramide (0.2 mg/kg/dose)
Number of subjects: 42
Study: 30055883

Group type: EXPERIMENTAL
Intervention: TAU + TCT
Number of subjects: 46

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 46
Study: 29200181

Group type: EXPERIMENTAL
Intervention: PROMIS pain interference scales (4 fixed-length scales including the 6-item Pain Short Form and the 4-, 6-, and 8-item pain interference scales)
Number of subjects: 759
Study: 23925581

Group type: EXPERIMENTAL
Intervention: Complex decongestive physical therapy (CDT) including skin care, manual lymphatic drainage, compression bandages, compression garments, and exercises, n = 15
Number of subjects: 31

Group type: COMPARATOR
Intervention: Complex decongestive physical therapy (CDT) combined with an intermittent pneumatic compression pump, n = 16
Number of subjects: 31
Study: 23780502

Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg film-coated tablets
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Montelukast 5 mg chewable tablets
Number of subjects: 76
Study: 21036743

Group type: EXPERIMENTAL
Intervention: Cetuximab and bevacizumab plus irinotecan (CBI)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Cetuximab and bevacizumab (CB)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Combined cetuximab and bevacizumab (CB)
Number of subjects: 65
Study: 18245934

Group type: EXPERIMENTAL
Intervention: Kangaroo mother care (KMC) for at least 6 hours per day
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standard care (incubator or open care system)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: KMC
Number of subjects: 110
Study: 16785774

Group type: EXPERIMENTAL
Intervention: High-intensity light treatment
Number of subjects: 63

Group type: COMPARATOR
Intervention: Medium-intensity light treatment
Number of subjects: 63
Study: 15582309

Group type: EXPERIMENTAL
Intervention: 600-mg loading dose of clopidogrel for 2 to 3 h
Number of subjects: 2159

Group type: EXPERIMENTAL
Intervention: 600-mg loading dose of clopidogrel for 3 to 6 h
Number of subjects: 2159

Group type: EXPERIMENTAL
Intervention: 600-mg loading dose of clopidogrel for 6 to 12 h
Number of subjects: 2159

Group type: EXPERIMENTAL
Intervention: 600-mg loading dose of clopidogrel for >12 h
Number of subjects: 2159

Group type: EXPERIMENTAL
Intervention: abciximab
Number of subjects: 2159

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2159
Study: 11179984

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg twice daily + Amoxicillin 750 mg twice daily
Number of subjects: 165

Group type: COMPARATOR
Intervention: Omeprazole 40 mg twice daily + Placebo
Number of subjects: 165
Study: 9067694

Group type: EXPERIMENTAL
Intervention: Neoral (microemulsion oral formulation of cyclosporine A)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Sandimmune SGC (oral cyclosporine A preparation)
Number of subjects: 5
Study: 8453694

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (1.5 g/m2)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Ifosfamide (5 g/m2)
Number of subjects: 135
Study: 3544649

Group type: EXPERIMENTAL
Intervention: 0.3 mg buprenorphine epidurally
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 0.9 mg buprenorphine epidurally
Number of subjects: 45
Study: 31874865

Group type: EXPERIMENTAL
Intervention: Stress management in addition to usual practice (restrictive diet, physical activity, and thermal spa treatment)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Usual practice (restrictive diet, physical activity, and thermal spa treatment)
Number of subjects: 140
Study: 29415787

Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac 15 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac 30 mg
Number of subjects: 0
Study: 27459533

Group type: EXPERIMENTAL
Intervention: Metformin (1 g twice daily)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: COMPARATOR
Intervention: Gliclazide (80 mg twice daily)
Number of subjects: 16
Study: 24825262

Group type: EXPERIMENTAL
Intervention: 300,000 IU of oral vitamin D3 (Group 1; n=38)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: 600,000 IU of oral vitamin D3 (Group 2; n=38)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 76
Study: 22979913

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate 2% mouthwash
Number of subjects: 60

Group type: COMPARATOR
Intervention: Herbal mouth wash
Number of subjects: 60
Study: 20616970

Group type: EXPERIMENTAL
Intervention: Community-directed intervention (CDI) including vitamin A supplementation, insecticide-treated nets, home management of malaria, and short-course, directly-observed treatment for tuberculosis patients.
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Community-directed intervention (CDI) for all five interventions.
Number of subjects: 35

Group type: COMPARATOR
Intervention: Comparison districts (control) with other delivery approaches.
Number of subjects: 35
Study: 18396744

Group type: EXPERIMENTAL
Intervention: 80 mL of NaP (two 40 mL doses separated by 24 h)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Standard 4‐liters PEG
Number of subjects: 182
Study: 11889278

Group type: EXPERIMENTAL
Intervention: Video-based intervention for nine weeks
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Telephone-based intervention for nine weeks
Number of subjects: 111

Group type: COMPARATOR
Intervention: Standard follow-up care
Number of subjects: 111
Study: 9451677

Group type: EXPERIMENTAL
Intervention: Homeopathic treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Homeopathic remedies < 12C
Number of subjects: 0

Group type: COMPARATOR
Intervention: Homeopathic remedies >= 12C
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8204351

Group type: EXPERIMENTAL
Intervention: Low dose rate (0.38 Gy/h)
Number of subjects: 155

Group type: COMPARATOR
Intervention: High dose rate (0.73 Gy/h)
Number of subjects: 155
Study: 3653228

Group type: EXPERIMENTAL
Intervention: 50 mg intravenously (i.v.) of ranitidine HCl
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 150 mg orally of ranitidine HCl
Number of subjects: 6
Study: 31735684

Group type: EXPERIMENTAL
Intervention: Incentive spirometry and deep breathing exercise (DBE)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Deep breathing exercise (DBE) only
Number of subjects: 90
Study: 29392332

Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (10 Hz, 10 sessions)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 12
Study: 28915863

Group type: EXPERIMENTAL
Intervention: Exercise intervention (3 months supervised exercise 2 times per week followed by 12 months active follow-up)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Exercise + diet intervention (exercise training with additional dietary counseling, 12 sessions over 15 months by a renal dietician)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 219
Study: 26613214

Group type: EXPERIMENTAL
Intervention: Early prophylactic INSURE with surfactant administration immediately after birth
Number of subjects: 80

Group type: COMPARATOR
Intervention: Later prophylactic INSURE with surfactant administration at the 15th minute after birth
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 23159770

Group type: EXPERIMENTAL
Intervention: PegIFNα‐2b (0.5 μg/kg/week)
Number of subjects: 540

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 540
Study: 20851617

Group type: EXPERIMENTAL
Intervention: Minimally invasive harvested grafts
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventionally harvested grafts
Number of subjects: 200
Study: 18198263

Group type: EXPERIMENTAL
Intervention: Higher initial fibrinogen level
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Lower FEV1
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Higher number of prestudy severe exacerbations
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Lower Dlco
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Higher number of prestudy moderate exacerbations
Number of subjects: 314
Study: 17163300

Group type: EXPERIMENTAL
Intervention: pegylated interferon‐alpha‐2a (IFNalpha‐2a)
Number of subjects: 186

Group type: COMPARATOR
Intervention: pegylated interferon‐alpha‐2b (IFNalpha‐2b)
Number of subjects: 186
Study: 12679210

Group type: COMPARATOR
Intervention: Stress perfusion scintigraphy (SPS), n = 35
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Fractional flow reserve (FFR), n = 35
Number of subjects: 70
Study: 10739429

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (tryptophan-free amino acid drink)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (balanced mixture of amino acids)
Number of subjects: 32
Study: 9370031

Group type: EXPERIMENTAL
Intervention: Occlusal adjustment therapy (performed at baseline and repeated every 6 months as needed)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Mock adjustments (control group)
Number of subjects: 123
Study: 1396808

Group type: EXPERIMENTAL
Intervention: Dobutamine stress echocardiography
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Dipyridamole stress echocardiography
Number of subjects: 46
Study: 30740765

Group type: EXPERIMENTAL
Intervention: STOMA psychosocial intervention programme
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study: 29175276

Group type: EXPERIMENTAL
Intervention: AVATAR therapy
Number of subjects: 150

Group type: COMPARATOR
Intervention: Supportive counselling
Number of subjects: 150
Study: 26985045

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation during saline infusion
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation during naloxone infusion
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group with saline infusion
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group with naloxone infusion
Number of subjects: 100
Study: 25033643

Group type: EXPERIMENTAL
Intervention: Analgesic drug treatment
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Psychological nursing interventions
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Psychological nursing intervention and analgesic drug treatment
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional nursing methods
Number of subjects: 120
Study: 22340260

Group type: EXPERIMENTAL
Intervention: ALT-836 (0.06 mg/kg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: ALT-836 (0.08 mg/kg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: ALT-836 (0.1 mg/kg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: ALT-836
Number of subjects: 18
Study: 18823760

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment
Number of subjects: 36385

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36385

Group type: COMPARATOR
Intervention: Probability of receiving placebo
Number of subjects: 36385

Group type: EXPERIMENTAL
Intervention: Baseline severity
Number of subjects: 36385

Group type: EXPERIMENTAL
Intervention: Year of publication
Number of subjects: 36385

Group type: EXPERIMENTAL
Intervention: Fixed versus flexible dose design
Number of subjects: 36385

Group type: EXPERIMENTAL
Intervention: Trial duration
Number of subjects: 36385

Group type: EXPERIMENTAL
Intervention: Population age
Number of subjects: 36385
Study: 17922880

Group type: EXPERIMENTAL
Intervention: AIR Insulin after 4-week smoking abstinence
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: AIR Insulin after smoking one cigarette (without NRT)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: AIR Insulin after 4-week smoking abstinence with NRT
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: AIR Insulin after smoking one cigarette with NRT
Number of subjects: 24
Study: 15935962

Group type: EXPERIMENTAL
Intervention: Soft mat without stabilised surface
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Mats with surface stabilising interface
Number of subjects: 6
Study: 14508022

Group type: EXPERIMENTAL
Intervention: Inhaled saline with suggestion of bronchoconstriction
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Inhaled saline with suggestion of bronchodilation
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Sham bronchoconstrictor
Number of subjects: 17
Study: 10934538

Group type: EXPERIMENTAL
Intervention: Quick Response Program (QRP) services
Number of subjects: 155

Group type: COMPARATOR
Intervention: Usual hospital care services
Number of subjects: 155
Study: 8522052

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (initial dose of 7.2 +/- 0.1 mg.kg-1.day-1, decreased stepwise and interrupted after 6-62 months)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Cyclosporin A
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 130
Study: 1815339

Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin dosed twice daily
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin dosed three times daily
Number of subjects: 131
Study: 6384419

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 29673262

Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy with exercise
Number of subjects: 110

Group type: COMPARATOR
Intervention: Spinal manipulative therapy without exercise
Number of subjects: 110
Study: 30186593

Group type: EXPERIMENTAL
Intervention: Manual Therapy (MT) as an add-on treatment after a single training session for GPs lasting two and a half hours.
Number of subjects: 87

Group type: COMPARATOR
Intervention: Standard care (Control Group).
Number of subjects: 87
Study: 27430386

Group type: EXPERIMENTAL
Intervention: ALA-DAG
Number of subjects: 19

Group type: COMPARATOR
Intervention: TAG
Number of subjects: 19
Study: 24828024

Group type: EXPERIMENTAL
Intervention: Vitamin D₃ supplementation (20 μg/d)
Number of subjects: 1122

Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 1122
Study: 22432107

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 259

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 259
Study: 19269127

Group type: EXPERIMENTAL
Intervention: Favorite-place group (visited favorite places at least once per day on 5 weekdays)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not-visiting group (visited favorite place 0-1 times)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (given instructions that did not mention favorite places)
Number of subjects: 0
Study: 17505374

Group type: EXPERIMENTAL
Intervention: LoFric catheter
Number of subjects: 196

Group type: COMPARATOR
Intervention: SpeediCath catheter
Number of subjects: 196